Study Reveals How Malaria Shaped 74,000 Years of Human Settlement Patterns

Recent research from the Max Planck Institute for Geoanthropology and the University of Cambridge reveals that malaria significantly impacted early humans, not just as a disease, but as a factor that influenced habitat selection, population fragmentation, and the genetic evolution of our species.

Colucci et al. investigated how Plasmodium falciparum-induced malaria influenced habitat selection among early human societies from 74,000 to 5,000 years ago.

“Malaria, a significant global health issue caused by the Plasmodium parasite, affects approximately 263 million people annually,” stated lead author Dr. Margherita Colucci and her team.

“Genetic evidence indicates that malaria posed a serious challenge during both recent prehistory and the Pleistocene epoch, with sickle cell anemia mutations linked to malaria emerging in Africa between 25,000 and 22,000 years ago.”

Archaeological findings also suggest that early humans developed tactics to minimize exposure to mosquitoes, such as using aromatic leaves with insecticidal properties in their surroundings.

The new study highlights how Plasmodium falciparum malaria played a crucial role in shaping human history in sub-Saharan Africa from 74,000 to 5,000 years ago.

Researchers discovered that malaria affected where early human populations settled, pushing them away from high-risk areas and leading to increased dispersal across various landscapes.

Over thousands of years, this demographic fragmentation influenced how groups intermingled and exchanged genetic material, ultimately shaping the genetic landscape of modern humans.

These findings suggest that malaria was more than just a health threat; it was a key factor in shaping human history.

“We utilized species distribution models for major mosquito groups alongside paleoclimate data,” explained Dr. Colucci.

“By integrating these findings with epidemiological insights, we estimated malaria transmission risks throughout sub-Saharan Africa.”

The researchers then compared these risk estimates with independent reconstructions of human ecological niches in the same regions during that time frame.

The results indicated that humans actively avoided high-risk malaria areas or could not survive in them.

Professor Andrea Manica remarked, “These decisions have significantly influenced human demographics over the past 74,000 years—and possibly beyond.”

“Malaria has played a pivotal role in shaping the structure of human societies.”

“Factors like climate and geographical barriers were not the only determinants of human habitation,” he added.

Professor Eleanor Seri noted, “This study opens new avenues in the exploration of human evolution, as disease has rarely been considered a driving force in our ancestry. Without ancient DNA from this period, verification would have been challenging.”

“Our research redefines this narrative and provides a new perspective on the role of disease in early human history.”

The findings are published in today’s edition of Scientific Advances.

_____

Margherita Colucci et al. 2026. Malaria’s impact on human spatial organization over 74,000 years. Scientific Advances 12(17); doi: 10.1126/sciadv.aea2316

Source: www.sci.news

Malaria drug shows promise in treating polycystic ovary syndrome

The malaria drug artemisinin is extracted from the plant wormwood.

Frederick J. Brown/AFP via Getty Images

A drug already used to treat malaria may also be effective in treating polycystic ovary syndrome (PCOS).

A small study of 19 women with PCOS found that the commonly used drug artemisinin improved menstrual cycle regularity and reduced high testosterone levels that are common in PCOS patients.

The underlying cause of PCOS is unknown, but it is linked to several hormonal imbalances, including excess testosterone produced by the ovaries, which can lead to symptoms like irregular menstrual periods, infertility, and increased acne and body hair.

Affected people also tend to have reduced sensitivity to insulin, the hormone that regulates sugar, which leads to weight gain and exacerbates the hormonal imbalance.

Currently, PCOS patients are treated individually depending on their symptoms, for example undergoing laser treatments to remove body hair or taking birth control pills to regularize menstruation.

While investigating the effects of various drugs on fat cells in mice, Chi Kun Tang Researchers at Fudan University in Shanghai, China, found that artemisinin reduced symptoms in mice with PCOS-like conditions.

His team then gave 19 women with PCOS artemisinin for three months and found that all of them experienced a drop in testosterone levels, and most also saw a reduction in another substance called anti-Müllerian hormone. Associated with PCOSTwelve of the participants also experienced more regular menstrual cycles after taking the drug.

In other studies using mouse and human cells, the team found that artemisinin could reduce testosterone production in the ovaries.

Stephen Franks The Imperial College London researcher says that although the 19 women had a healthy BMI on average, weight loss tends to reduce PCOS symptoms, suggesting that artemisinin may work through another mechanism: improving insulin sensitivity. “If the results are as positive in a randomized trial as they are in this pilot study, it would be exciting,” he says.

Elisabeth Stener-Victorin Researchers at the Karolinska Institutet in Stockholm, Sweden, say the fact that artemisinin is already generally safe when used to treat malaria means that it could soon be repurposed as a new treatment for PCOS.

topic:

Source: www.newscientist.com